• The global Endocarditis Drug Market is expected to gain market growth in the forecast period of 2025 to 2032. Data Bridge Market Research analyzes the market to account for growth at a CAGR of 6.7% in the above-mentioned forecast period.
• Endocarditis is a potentially life-threatening inflammation of the inner lining of the heart chambers and valves, usually caused by bacterial or fungal infection. It can lead to severe complications including heart failure, stroke, and systemic infection if left untreated.
• The rise in risk factors such as prosthetic heart valves, congenital heart defects, intravenous drug use, increasing government initiatives for infectious disease control, technological advancements in diagnostics, and rising healthcare expenditures are key factors driving the growth of the global Endocarditis Drug Market
